GPTHEALTH

GPT Healthcare Shareholding Pattern

₹146.34-1.13%
Market cap
₹1,201 crore
P/E
25.4
P/B
4.46
ROE
16.3%
Dividend yield
1.03%

As of 30-JUN-2026, promoters held 65.57% of GPT Healthcare (0.00 pp from 31-MAR-2026), foreign institutional investors 3.03%, domestic institutions 6.94% and the public 24.46%.

GPT Healthcare shareholding pattern

Percentage of shares held, by quarter, newest first.

GPT Healthcare shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters65.57%65.57%65.57%65.57%65.57%n/a0.00 pp
Foreign institutions (FII/FPI)3.03%2.81%2.74%3.20%4.96%n/a+0.22 pp
Domestic institutions (DII)6.94%6.83%6.20%6.46%9.32%n/a+0.11 pp
Public24.46%24.78%25.49%24.76%20.15%n/a-0.32 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

GPT Healthcare shareholding pattern — frequently asked questions

What is the promoter holding in GPT Healthcare?

Promoters held 65.57% of GPT Healthcare as of 30-JUN-2026, unchanged from 65.57% in 31-MAR-2026.

How much do FIIs hold in GPT Healthcare?

Foreign institutional investors held 3.03% of GPT Healthcare as of 30-JUN-2026, a change of +0.22 pp from the previous quarter.

How much do domestic institutions hold in GPT Healthcare?

Domestic institutional investors, including mutual funds and insurers, held 6.94% of GPT Healthcare as of 30-JUN-2026 (+0.11 pp from the previous quarter).

Who owns GPT Healthcare?

As of 30-JUN-2026, GPT Healthcare's shareholders were promoters (65.57%), foreign institutional investors 3.03%, domestic institutions 6.94% and the public 24.46%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade GPT Healthcare With ATS

Track GPTHEALTH live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

GPT Healthcare share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.